Literature DB >> 25407540

Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.

S O'Neill1, L O'Driscoll.   

Abstract

Obesity is reaching epidemic proportions with recent worldwide figures estimated at 1.4 billion and rising year-on-year. Obesity affects all socioeconomic backgrounds and ethnicities and is a pre-requisite for metabolic syndrome. Metabolic syndrome is a clustering of risk factors, such as central obesity, insulin resistance, dyslipidaemia and hypertension that together culminate in the increased risk of type 2 diabetes mellitus and cardiovascular disease. As these conditions are among the leading causes of deaths worldwide and metabolic syndrome increases the risk of type 2 diabetes mellitus fivefold and cardiovascular disease threefold, it is of critical importance that a precise definition is agreed upon by all interested parties. Also of particular interest is the relationship between metabolic syndrome and cancer. Metabolic syndrome has been associated with a plethora of cancers including breast, pancreatic, colon and liver cancer. Furthermore, each individual risk factor for metabolic syndrome has also an association with cancer. Our review collates internationally generated information on metabolic syndrome, its many definitions and its associations with life-threatening conditions including type 2 diabetes mellitus, cardiovascular disease and cancer, providing a foundation for future advancements on this topic.
© 2014 The Authors Obesity Reviews published by John Wiley & Sons Ltd on behalf of International Association for the Study of Obesity (IASO).

Entities:  

Keywords:  Cancer; cardiovascular disease; metabolic syndrome; type 2 diabetes mellitus

Mesh:

Year:  2014        PMID: 25407540     DOI: 10.1111/obr.12229

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  400 in total

1.  Age at Onset of Metabolic Syndrome Among Women With and Without Polycystic Ovary Syndrome-Like Status.

Authors:  Qing Peng; Carrie A Karvonen-Gutierrez; John F Randolph; Bin Nan; Daniel McConnell; Siobán D Harlow
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

2.  Three types of a high-carbohydrate diet are differently associated with cardiometabolic risk factors in Korean adults.

Authors:  SuJin Song; YoonJu Song
Journal:  Eur J Nutr       Date:  2018-12-05       Impact factor: 5.614

Review 3.  Red blood cell components: time to revisit the sources of variability.

Authors:  Rosemary L Sparrow
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

4.  Delaware's 1999-2017 Leading Causes of Death Information Illustrates Its Obesity and Obesity-Related Life-Limiting Disease Burdens.

Authors:  Malcolm J D'Souza; Riza C Li; Derald E Wentzien
Journal:  Res Health Sci       Date:  2019-11-12

Review 5.  NAD+ metabolism and retinal degeneration (Review).

Authors:  Andreea Silvia Pîrvu; Ana Marina Andrei; Elena Camelia Stănciulescu; Ileana Monica Baniță; Cătălina Gabriela Pisoschi; Sanda Jurja; Radu Ciuluvica
Journal:  Exp Ther Med       Date:  2021-04-23       Impact factor: 2.447

Review 6.  Selenium, Vanadium, and Chromium as Micronutrients to Improve Metabolic Syndrome.

Authors:  Sunil K Panchal; Stephen Wanyonyi; Lindsay Brown
Journal:  Curr Hypertens Rep       Date:  2017-03       Impact factor: 5.369

7.  Association between intensive health guidance focusing on eating quickly and metabolic syndrome in Japanese middle-aged citizens.

Authors:  Daisuke Ekuni; Michiko Furuta; Toshihide Kimura; Naoki Toyama; Daiki Fukuhara; Yoko Uchida; Nanami Sawada; Manabu Morita
Journal:  Eat Weight Disord       Date:  2018-06-07       Impact factor: 4.652

Review 8.  β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes.

Authors:  Laura I Hudish; Jane Eb Reusch; Lori Sussel
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

9.  GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials.

Authors:  Chuqing Cao; Shuting Yang; Zhiguang Zhou
Journal:  Endocrine       Date:  2019-08-16       Impact factor: 3.633

Review 10.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.